This paper deals with science in Slovakia and in European Union. In the first part, the science in Slovakia is analysed and also described in the international context. There is concluded in this part, that desired economics, social and technological sources and institutional structures as well, are still missing. In the second part are depicted science prospects in the European Union. In the third part of the paper, the tendencies in the Slovak research and development system up to 2015 are outlined. The resources are aimed at the following priority areas: development and use of advanced technologies; support to sustainable development; rise of innovation performance in society.
This paper analyses development of the private R&D system in Slovakia after 1989. In 1990s, Slovakia experienced a painful economic transition, privatization and influx of the foreign direct investment. These developments were major factors behind sharp fall in R&D spending and levels of innovativeness. Moreover, Slovakia became a dual economy. Branch-plants of the multinational companies benefited from technology diffusion and accounted for the high productivity levels. The domestic companies generated low demand on innovative solutions and competed with the low costs of production. There, however, were some 'islands of excellence'. This was a case of the 'Zentiva' pharmaceutical firm, which accounted for a distinctive system of R&D and innovation patterns. The 'Zentiva' case study is analysed via patterns of corporate governance, entry of a smart foreign investor and firm's international expansion. Concluding chapter summarizes the findings on role of FDI in fostering innovations and private R&D.
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.